FDA Revokes Approval For 7 Acetaminophen Painkillers
Law360, New York (July 16, 2014, 7:05 PM EDT) -- The U.S. Food and Drug Administration on Wednesday revoked approval for seven narcotic painkillers that contain acetaminophen, including versions of AbbVie Inc.’s Vicodin, in the agency’s latest action in response to concerns about the ingredient’s potential to cause severe liver damage.
The move comes more than three years after regulators announced plans to cap the amount of acetaminophen in prescription drugs at 325 milligrams per dose. Three versions of AbbVie’s Vicodin, which combines acetaminophen and hydrocodone, were affected by the action.
Two similar products sold by Actavis Inc. and Nesher Pharmaceuticals USA LLC also had their approvals withdrawn. And products made...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!